These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1003699)

  • 1. Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle.
    Himori N; Ono H; Taira N
    Jpn J Pharmacol; 1976 Aug; 26(4):427-35. PubMed ID: 1003699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronotropic effects of coronary vasodilators as assessed in the isolated, blood-perfused sino-atrial node preparation of the dog.
    Ono H; Himori N; Taira N
    Tohoku J Exp Med; 1977 Apr; 121(4):383-90. PubMed ID: 867424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on mechanisms of diltiazem-induced protection of the ischemic myocardium: selective myocardial depressant action of diltiazem on an ischemic isolated blood-perfused canine papillary muscle preparation.
    Ngai JH; Yabuuchi Y; Schwartz A; Millard RW
    J Pharmacol Exp Ther; 1983 May; 225(2):462-9. PubMed ID: 6842404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
    Kawada M; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcium-antagonistic coronary vasodilators, nifedipine and verapamil, on ventricular automaticity of the dog.
    Endoh M; Yanagisawa T; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):235-8. PubMed ID: 652065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac versus coronary vasodilator actions of KB-944, a new calcium antagonist, assessed in isolated, blood-perfused heart preparations of dogs.
    Taira N; Kawada M; Satoh K
    J Cardiovasc Pharmacol; 1983; 5(3):349-56. PubMed ID: 6191131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.
    Narimatsu A; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):169-77. PubMed ID: 1012337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
    Motomura S; Hashimoto K; Hashimoto K
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
    Urquhart J; Epstein SE; Patterson RE
    Am J Cardiol; 1985 Jan; 55(3):10B-16B. PubMed ID: 3969856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
    Satoh K; Yanagisawa T; Taira N
    Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of quinidine on blood flow rate and developed tension in blood-perfused canine papillary muscle.
    Himori N; Taira N
    Clin Exp Pharmacol Physiol; 1976; 3(1):1-7. PubMed ID: 971549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs.
    Urquhart J; Patterson RE; Bacharach SL; Green MV; Speir EH; Aamodt R; Epstein SE
    Circulation; 1984 Feb; 69(2):382-90. PubMed ID: 6690104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of a new calcium antagonist, FR 7534, nitroglycerin, and dipyridamole on regional myocardial blood flow and cardiac contractility during partial coronary artery occlusion in the dog.
    Gross GJ; Warltier DC; Jolly SR; Hardman HF
    J Cardiovasc Pharmacol; 1980; 2(6):797-813. PubMed ID: 6160329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations.
    Hugtenburg JG; Mathy MJ; Boddeke HW; Beckeringh JJ; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):567-75. PubMed ID: 2615848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations.
    Imagawa J; Satoh K; Taira N
    Heart Vessels; 1987; 3(4):182-9. PubMed ID: 3453824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
    Robertson MJ; Lumley P
    Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.